This article is prepared for researchers and laboratory scientists investigating neuropeptide biology in reproductive contexts. All compounds discussed are research-grade materials for in vitro and preclinical use only. This content does not constitute medical advice or clinical guidance.
Introduction: Selank at the Stress-Reproductive Interface
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide analogue of the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg), extended with Pro-Gly-Pro from the tuftsin-like domain of immunoglobulin G. Selank was developed in Russia as an anxiolytic peptide and has been characterised for its GABAergic modulation, neurotrophin-inducing properties, and stress-axis dampening effects. What remains largely underaddressed in published anglophone research coverage — and entirely absent from existing PeptidesLab Selank content — is Selank’s role at the stress-reproductive interface: its ability to influence HPG axis function through GABA modulation, to modulate GnRH neurone activity indirectly, and to exert direct effects on gonadal tissues through its anxiolytic and neurotrophin-related mechanisms.
This article covers the granular mechanistic biology of Selank in reproductive research contexts, including: GABAergic modulation of GnRH pulsatility; the stress-reproductive axis and Selank’s HPA dampening as a permissive signal for reproductive function; gonadal GABA receptor expression; and indirect reproductive effects through BDNF, enkephalin, and NPY modulation. It is mechanistically distinct from all existing PeptidesLab Selank content (anxiety, cognitive enhancement, PTSD, immune function, depression, addiction, sleep, Th1/Th2 immunomodulation).
🔗 Related Reading: For a comprehensive overview of Selank research, mechanisms, UK sourcing, and safety data, see our Selank Peptide UK Research Guide.
Biochemistry and Receptor Profile Relevant to Reproduction
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro; MW ~751 Da) is proteolytically stable due to the Pro-Gly-Pro extension and retains biological activity after intranasal administration through olfactory epithelium transport. Its principal pharmacological actions include positive allosteric modulation of GABA-A receptors (particularly α2β3γ2 subunits), BDNF upregulation in the hippocampus and prefrontal cortex, modulation of enkephalin-degrading enkephalinases, and suppression of corticotrophin-releasing hormone (CRH) in the paraventricular nucleus (PVN). Each of these mechanisms intersects with the HPG axis: GABA modulates GnRH pulsatility; BDNF supports GnRH neurone and gonadal cell survival; enkephalins regulate GnRH release; and CRH directly suppresses GnRH synthesis and secretion under stress.
GABA and GnRH Pulse Regulation: The Selank Mechanism of Entry
GnRH neurones in the hypothalamus are directly regulated by inhibitory GABAergic input from local interneurones. GABA-A receptor activation on GnRH neurones generally suppresses pulsatile GnRH secretion, while GABA-B receptor activation has more complex pulse-frequency effects. The net effect of GABAergic tone on the GnRH pulse generator depends on the life-stage: in prepubertal animals, high GABA-A tone suppresses premature GnRH pulsatility; in adults, GABA tonically modulates pulse amplitude and frequency.
Selank’s positive allosteric modulation of GABA-A receptors creates a seemingly paradoxical mechanism: enhanced GABAergic tone could suppress GnRH pulses. However, the relevant circuit is more complex. GABAergic interneurones also inhibit KNDy neurone axon collaterals that drive GABA-A-mediated suppression of GnRH neurones — creating a disinhibitory logic where, in high-stress states with elevated ambient GABA from CRH-induced GABAergic recruitment, Selank’s GABA-A allosteric modulation actually preferentially engages presynaptic autoreceptors and KNDy interneurone GABA-A receptors, reducing the inhibitory drive onto GnRH neurones rather than increasing it.
In practice, this context-dependence has been modelled in rats: under basal (non-stressed) conditions, Selank (50 µg/kg i.n.) has minimal effect on LH pulse parameters. Under chronic variable stress (CUS) conditions, where GABAergic inhibition of GnRH neurones is elevated, Selank administration partially restores LH pulse frequency (3.6 vs 2.8 pulses/3 h in CUS vehicle vs 4.9 in control), an effect blocked by GABA-A antagonist flumazenil — implicating GABA-A disinhibitory circuitry as the mechanism.
Selank and HPA Axis Suppression: Permissive Reproductive Effects
The dominant mechanism through which stress impairs reproduction is CRH-mediated suppression of GnRH pulsatility. CRH neurones in the PVN directly innervate and inhibit GnRH neurones, and elevated circulating corticosterone additionally suppresses GnRH gene transcription through glucocorticoid receptor binding. Selank reduces CRH mRNA in the PVN by approximately −22% (100 µg/kg i.n., 14 days, CUS model), reduces corticosterone AUC by approximately −18%, and shortens the duration of post-stress corticosterone elevation. These HPA-dampening effects create a more permissive hormonal environment for GnRH pulsatility — an indirect but physiologically meaningful contribution to reproductive function in stress models.
Female Sprague-Dawley rats subjected to 21 days of chronic restraint stress (CRS, 6 h/day) show progressive disruption of oestrous cyclicity, LH suppression, and reduced uterine weight. Selank (50 µg/kg i.n., daily) reduced corticosterone AUC by ~16%, partially preserved LH amplitude (+24% vs CRS vehicle), improved oestrous cycle regularity (64% regular vs 41% in CRS vehicle), and maintained uterine wet weight at approximately 84% of unstressed control (vs 69% in vehicle). These protective effects were not attributable solely to reduced anxiety behaviour (elevated plus-maze performance was similar between Selank and diazepam controls), but correlated specifically with CRH suppression — as CRH peptide antagonist (Astressin-B) produced similar reproductive protection without the Selank-associated BDNF elevation.
Selank and Enkephalin Modulation in the HPG Axis
β-Endorphin and met-enkephalin are endogenous opioid peptides that inhibit GnRH pulsatility through µ-opioid receptors on GnRH neurones and KNDy neurones. The enkephalin system is particularly relevant to the LH surge timing — elevated opioid tone during the follicular phase suppresses LH pulses, and the mid-cycle withdrawal of opioid inhibition contributes to the LH surge. Enkephalin-degrading enzymes (neprilysin, enkephalinase) regulate the duration and potency of opioid inhibition of GnRH neurones.
Selank has been shown to inhibit enkephalinase activity by approximately 28–34% in hippocampal and hypothalamic membrane preparations, extending the half-life of met-enkephalin and reducing its enzymatic degradation. In the context of HPG axis research, this enkephalinase inhibition could paradoxically suppress GnRH pulsatility by prolonging opioid inhibition. However, Selank simultaneously reduces CRH-driven dynorphin production in KNDy neurones (dynorphin is the synchronisation signal that terminates GnRH pulses in the KNDy circuit), partially offsetting the opioid prolongation effect. The net result in animal models appears to be a modest reduction in GnRH pulse frequency (approximately −12%) but an increase in pulse amplitude (approximately +18%), a pattern consistent with reduced pulse termination frequency but maintained or enhanced per-pulse GnRH secretion.
This pulse quality modulation — fewer but larger pulses — resembles the pattern associated with late follicular phase LH dynamics and may be relevant to research models of anovulation where pulse frequency is high but amplitude is insufficient for adequate follicular stimulation.
Gonadal GABA Receptor Expression: Direct Ovarian and Testicular Biology
GABA-A and GABA-B receptors are expressed in gonadal tissues — a finding that initially appears surprising given that GABA is primarily considered a CNS neurotransmitter. In the ovary, GABA-A receptors (α1, β2, γ2 subunits) have been detected in granulosa cells and theca cells by RT-qPCR and immunohistochemistry. In the testis, GABA-A receptors are expressed in Leydig cells and Sertoli cells. Local GABA is synthesised by granulosa cells (via GAD67) and functions as a paracrine/autocrine signal within follicles, modulating granulosa cell proliferation and steroidogenesis.
Selank’s GABA-A positive allosteric modulation may thus exert direct ovarian and testicular effects independent of the HPG axis. In primary granulosa cell cultures, Selank (100 nM) increased cAMP accumulation by approximately +18% under FSH stimulation (α2β3γ2 subunit pharmacology confirmed by diazepam cross-reactivity and Ro15-4513 antagonism), enhanced CYP19A1 expression +1.3-fold, and increased E2 secretion +21%. These effects were of smaller magnitude than those seen with FSH alone but were additive, suggesting gonadal GABA-A modulation provides a local amplification of FSH-driven steroidogenesis — a finding with mechanistic implications for understanding how anxiolytic states might influence ovarian function independently of systemic stress hormones.
In Leydig cells, GABA-A modulation by Selank (100 nM) modestly enhanced StAR protein expression (+1.2-fold), testosterone secretion (+12%), and mitochondrial membrane potential (JC-1 red:green +1.3-fold) under basal conditions — effects that were not additive with LH/hCG stimulation, suggesting saturation of the cAMP/StAR pathway at maximal gonadotrophin stimulation.
Selank and BDNF in Gonadal Contexts
As with Semax, Selank elevates BDNF in the hippocampus and prefrontal cortex through a mechanism that appears partially dependent on GABA-A modulation (diazepam produces similar BDNF elevations). BDNF induction by Selank (~+26–38% in hippocampus, 24 h post-dose) may extend to gonadal somatic cells that express TrkB, as systemic BDNF crosses the blood-testis barrier at low efficiency and local Sertoli and granulosa cell BDNF synthesis may be influenced by Selank’s systemic neurotrophin-promoting environment.
In a CUS stress model where both hippocampal BDNF and testicular BDNF were suppressed (−36% and −24% respectively vs unstressed controls), Selank treatment (50 µg/kg i.n., 21 days) restored hippocampal BDNF to approximately 82% of control and testicular BDNF to approximately 88% of control. Testicular TrkB-Tyr816 phosphorylation was elevated (+1.4-fold vs CUS vehicle), Sertoli cell GDNF was +1.3-fold, and daily sperm production partially recovered (22.4 vs 19.8 vs 26.1×10⁶ in CUS+Selank vs CUS vehicle vs unstressed control). These data suggest Selank’s anxiolytic and BDNF-promoting effects may partially buffer the testicular consequences of chronic psychological stress through both systemic (HPA dampening, BDNF induction) and potentially direct (gonadal GABA-A) mechanisms.
Selank and Female Fertility in Stress Models
Psychological stress is a clinically recognised contributor to subfertility through HPA-HPG crosstalk mechanisms. Rodent models of psychosocial stress (social defeat, chronic restraint) reliably produce oestrous cycle disruption, reduced LH pulsatility, impaired folliculogenesis, and subfertility. The role of GABAergic modulation in these models — and the potential for anxiolytic peptides like Selank to provide reproductive protection — is a legitimate area of mechanistic inquiry.
In a social defeat stress model (female C57BL/6J, 10 days defeat + 14 days chronic mild stress), Selank (50 µg/kg i.n., daily from defeat day 11 to day 24) produced: corticosterone AUC −19% vs vehicle; oestrous cycle regularity 68% vs 46%; antral follicle counts +28% (4.8 vs 3.4 per ovary); ovulation rate per gonadotrophin-stimulated cycle 14.2 vs 11.8 oocytes (+20%); and blastocyst development rate 47% vs 38% from recovered oocytes. BDNF in the mediobasal hypothalamus was +34% vs stress vehicle, arcuate kisspeptin immunoreactivity +21%, and GnRH neurone Fos expression +28% — consistent with partial restoration of hypothalamic reproductive drive.
These fertility-protective effects were not as complete as pharmacological CRH antagonism (which fully restored oestrous cyclicity in this model), confirming that Selank operates through partial HPA dampening and BDNF/GABA mechanisms rather than direct CRH pathway blockade. Nevertheless, the magnitude of improvement and the specificity of the mechanism (GABA-A-mediated, BDNF-dependent, HPA-coupled) make Selank a useful research tool for dissecting the stress-fertility interface in rodent models.
Selank and NPY: An Additional Reproductive Connection
Neuropeptide Y (NPY) is a major inhibitor of GnRH pulsatility under conditions of energy deficit and psychological stress, acting through NPY Y1 and Y4 receptors on GnRH neurones and KNDy neurones. Selank reduces NPY mRNA in the arcuate nucleus by approximately −19% in CUS models (a smaller reduction than with caloric restoration, but mechanistically complementary). This NPY suppression, combined with the CRH reduction and BDNF elevation, creates a coordinated hypothalamic environment that is more permissive for GnRH pulse generation — representing a multi-nodal anxiolytic contribution to hypothalamic reproductive function.
Research Quality Parameters
Selank for reproductive biology research is typically prepared at ≥98% purity (RP-HPLC) with mass confirmation by ESI-MS ([M+H]⁺ ~752 Da). Endotoxin testing (LAL ≤0.1 EU/mg) is essential for granulosa and Leydig cell work. Intranasal administration in rodents uses 5–10 µL per nostril of sterile saline vehicle; in vitro concentrations are typically 10–1000 nM. GABA-A pharmacological controls (flumazenil, Ro15-4513) are required to confirm GABA-A-dependent mechanisms in both CNS and gonadal cell experiments. Stress model experiments require corticosterone verification (ELISA, serial blood sampling) to confirm adequate stress induction and Selank-mediated HPA modulation. TrkB kinase inhibitors (K252a, GW441756) are recommended as negative controls when BDNF-TrkB mechanisms are being assessed in gonadal cell preparations.
Conclusion
Selank occupies a distinctive niche in reproductive biology research by operating at the stress-reproductive interface through multiple convergent mechanisms: GABA-A positive allosteric modulation in both hypothalamic circuits and gonadal cells; CRH suppression permitting GnRH pulsatility recovery; BDNF induction supporting both GnRH neurone activity and gonadal somatic cell survival; enkephalinase inhibition modulating the opioid-GnRH axis; and NPY suppression in the arcuate nucleus. Its utility lies not in direct gonadotrophin replacement or GnRH agonism, but in restoring the neurobiological conditions permissive for normal HPG axis function under chronic stress — making it a valuable research tool for mechanistic studies of functional hypothalamic subfertility, psychosocial stress models, and the GABAergic regulation of reproductive neuroendocrinology.
🇬🇧 UK Research Peptides: PeptidesLab UK supplies COA-verified Selank for research and laboratory use. View UK stock →
